Financials

Discussions Technicals Seasonals

CURE.X fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Biocure Technology, Inc. engages in the development and commercialization of biosimilar products. Its also offers CAR-T Cell immunotherapy, hair growth treatment, and FMD vaccine products. The company was founded on August 24, 2007 and is headquartered in Vancouver, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

CURE.X does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company